RT Journal Article
SR Electronic
T1 Aspirin for primary prevention of atherosclerotic cardiovascular events
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 300
OP 311
DO 10.3949/ccjm.87a.19045
VO 87
IS 5
A1 Aldo L. Schenone
A1 A. Michael Lincoff
YR 2020
UL http://www.ccjm.org/content/87/5/300.abstract
AB Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.